Loading clinical trials...
Loading clinical trials...
Safety and Immunogenicity of COVID-19 Vaccine Administered in Older Adults: A Multicenter Prospective Study
Conditions
Interventions
COVID-19 Vaccine
Locations
1
China
302 Hospital
Beijing, China
Start Date
July 28, 2021
Primary Completion Date
August 31, 2022
Completion Date
September 30, 2022
Last Updated
August 19, 2021
NCT06791356
NCT07379099
NCT05978336
NCT07315724
NCT07171164
NCT07199426
Lead Sponsor
Beijing 302 Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions